28 Nov 20 | Shanghai Henlius Biotech reported positive results from Ph III trials of its biosimilar bevacizumab candidate.
01 Dec 20 | US | US District Court Judge Leonard Stark refused to grant costs in the Coherus/Amgen (pegfilgrastim) matter. Coherus argued that fees were warranted because Amgen had pursued a baseless claim and appeal, intending to thwart competition.